Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Glioblastoma Targeted Treatment Option Maximization by Whole Genome Sequencing

NCT05186064 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT05186064
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05186064 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Glioblastoma Targeted Treatment Option Maximization by Whole Genome Sequencing
Lead sponsor
UMC Utrecht
Phase
Not applicable
Overall status
Completed
Start date
July 25, 2022
Completion date
December 1, 2025
Enrollment
164 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma